In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences (Q39485814)

12 September 2017

1 reference

title

In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences (English)

1 reference

12 September 2017

0 references

5

Dannals RF

1 reference

12 September 2017

1

Wong DF

1 reference

12 September 2017

Broussolle EP

2

1 reference

12 September 2017

Wand G

3

1 reference

12 September 2017

Villemagne V

4

1 reference

12 September 2017

Links JM

6

1 reference

12 September 2017

Zacur HA

7

1 reference

12 September 2017

Harris J

8

1 reference

12 September 2017

Naidu S

9

1 reference

12 September 2017

Braestrup C

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

12 September 2017

published in

1 reference

12 September 2017

volume

515

1 reference

12 September 2017

page(s)

203-214

1 reference

describes a project that uses

12 September 2017

positron emission tomography

1 reference

based on heuristic

inferred from title

cites work

Central neurotransmitters and aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Changes in the mechanisms of hormone and neurotransmitter action during aging: Current status of the role of receptor and post-receptor alterations. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Neurotransmitter receptors in the central nervous system and aging: Pharmacological aspect (review)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Aging process affects a single class of dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Reduced dopaminergic binding during aging in the rodent striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Neurochemistry of dopamine in Huntington's dementia and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Imaging dopamine receptors in the human brain by positron tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Dopamine receptor binding in vivo: The feasibility of autoradiographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Human cerebral blood flow and oxygen consumption as related to aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Estradiol suppresses then enhances intracaudate dopamine-induced contralateral deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Pre- and postsynaptic neurochemical alterations following estrogen-induced striatal dopamine hypo- and hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Effect of estrogens on dopamine autoreceptors in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Effects of estrogen on the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Modulation of brain and pituitary dopamine receptors by estrogens and prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Age alters dopaminergic responses to estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Estrogen replacement and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

Comparison of the CNS effects induced by TRH and bicuculline after microinjection into medial septum, substantia nigra and inferior colliculus: absence of support for a GABA antagonist action for TRH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB32986.X

10.1111/J.1749-6632.1988.TB32986.X

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference